COVID-19 Clinical Trials in Phoenix

Showing 81-100 of 112 trials

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

NCT04421508

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

COVID-19CoronavirusCoronavirus Infection

Bellerophon Pulse Technologies191 participantsStarted Jul 2020

Phoenix, Arizona, United States • San Diego, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 2< 1 mile

Sargramostim Use in COVID-19 to Recover Patient Health

NCT04707664

The purpose of this research is to understand if the study drug, also called sargramostim or Leukine®, can help prevent the worsening of COVID-19 when the study drug is inhaled. This study will also help researchers understand if inhaled sargramostim can help prevent visits to the emergency room or hospitalization, or death.

Covid19SARS-CoV Infection

Partner Therapeutics, Inc.600 participantsStarted Apr 2021

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Canoga Park, California, United States +34 more locations

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Sargramostim Use in COVID-19 to Recover Patient Health

COVID-19 Trials in Other Cities

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

COVID-19 Progression in End-Stage Kidney Disease

Adaptive COVID-19 Treatment Trial (ACTT)

A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

A Study of Immune Responses to the Virus That Causes COVID-19

Treatment for COVID-19 in High-Risk Adult Outpatients

CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1)

Medical Masks vs N95 Respirators for COVID-19

Other Conditions in Phoenix